EP1132430B1 - Organopolysiloxane gels for use in cosmetics - Google Patents

Organopolysiloxane gels for use in cosmetics Download PDF

Info

Publication number
EP1132430B1
EP1132430B1 EP01101608A EP01101608A EP1132430B1 EP 1132430 B1 EP1132430 B1 EP 1132430B1 EP 01101608 A EP01101608 A EP 01101608A EP 01101608 A EP01101608 A EP 01101608A EP 1132430 B1 EP1132430 B1 EP 1132430B1
Authority
EP
European Patent Office
Prior art keywords
gel
organopolysiloxane
weight
unsaturated
hydrophile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01101608A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP1132430A1 (en
Inventor
Bryan E. Fry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wacker Chemie AG
Original Assignee
Wacker Chemie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wacker Chemie AG filed Critical Wacker Chemie AG
Publication of EP1132430A1 publication Critical patent/EP1132430A1/en
Application granted granted Critical
Publication of EP1132430B1 publication Critical patent/EP1132430B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04Polysiloxanes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/12Polysiloxanes containing silicon bound to hydrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/20Polysiloxanes containing silicon bound to unsaturated aliphatic groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/80Siloxanes having aromatic substituents, e.g. phenyl side groups

Definitions

  • the present invention pertains to organopolysiloxane gels suitable for use in cosmetic applications which can form stable emulsions with hydrophilic liquids such as water and glycols.
  • Organopolysiloxanes have been used in numerous cosmetic applications for many years. In some of these applications, for example, organopolysiloxanes such as silicone fluids have been employed, either in their native form as oleaginous carriers for other cosmetic ingredients, or in the form of oil-in-water emulsions. In many of the latter cases, a surfactant is necessary in order to keep the silicone fluid in stable suspension or dispersion.
  • organopolysiloxanes such as silicone fluids
  • silicone fluids such as silicone fluids
  • a surfactant is necessary in order to keep the silicone fluid in stable suspension or dispersion.
  • numerous cosmetic formulations have employed creams or pastes which include organopolysiloxane gels containing volatile organosiloxanes.
  • U.S. Patent 5,654,362 discloses silicone gels prepared by reacting a linear, Si-H functional polysiloxane with an ",T--diene, for example 1,5-hexadiene, in the presence of a platinum hydrosilylation catalyst and a low molecular weight silicone oil. The reaction is continued until a gel is formed following which the silicone gel may be crumbled into a powder, or by addition of further silicone oil, may form a silicone paste. The products are employed to thicken hydrophobic liquids such as silicone oils to a gel-like consistency.
  • a variety of cosmetic products such as an anti-perspirants, deodorants, skin creams, etc.,are disclosed.
  • the use of expensive and flammable diene hydrocarbons in the preparation is a disadvantage.
  • creams formed from solid powders are said not to provide acceptable properties, as indicated by U.S. Patent 4,980,167, wherein such formulations are said to suffer from lack of lubricity.
  • Similar products prepared from ",T-dienes and polyether-functional siloxanes are disclosed in U.S. 5,136,068. However, preparation of water-in-oil emulsions still required use of a separate emulsifying surfactant.
  • U.S. Patent 4,987,169 discloses preparation of linear and lightly crosslinked organosiloxanes in the presence of silicone oils to form soft powdery or soft, translucent solid particles.
  • the crosslinked organosiloxanes are preferably prepared employing linear Si-H and vinyl-functional organopolysiloxanes, crosslinked through the aid of a hydrosilylation catalyst. Because of the limited crosslinking of the crosslinked organosiloxanes, the amount of the latter necessary to produce the solid product is high, for example 30 to 50% by weight. The product is thus relatively expensive.
  • the soft powders may be used as thickeners in solubilizing additional silicone oil to form greasy compositions stated to be useful in cosmetics and lubricants.
  • U.S. Patent 5,760,116 discloses products prepared in two stages, in a first step, preparing a highly crosslinked gel from an Si-H functional organopolysiloxane resin in the presence of a minor amount of low viscosity organopolysiloxane, and in a second step, adding further organopolysiloxane oil by means of a homogenizer into the gel by means of a homogenizer to produce a clear, highly viscous liquid.
  • the disadvantage of two stage production is clear.
  • U.S. Patent, 5,859,069 discloses a gelatinous external skin treatment composition prepared from an organopolysiloxane elastomer powder having spherical particles with an average particle size of 1.0 to 15.0 :m, a silicone oil, and a polyether-modified silicone.
  • the '069 patent indicates that prior formulations employing silicone resins are unsuitable for such uses, as they leave a filmy feeling on the skin.
  • the polyether-modified, resin-free (linear) silicone is disclosed as being absolutely necessary; and if amounts of less than 1.0% by weight are used, gelation becomes insufficient and the composition becomes unsuitable for use in cosmetics.
  • Gelatinous external skin treatment compositions containing the spherical powder, 5-75% by weight of silicone oil, and 1-20% by weight of polyether-modified silicone are disclosed. Preparation of spherical elastomer particles is not straightforward, and creams containing solid powders have been viewed as undesirable,-as previously discussed.
  • Polyether-functionalized silicone surfactants are disclosed in U.S. Patents 5,412,004 and 5,236,986. In each case, a polyether-functional linear Si-H containing organopolysiloxane is reacted with an ",T-divinyl organopolysiloxane.
  • a further series of compounds are prepared by cross-linking employing an ",T-bis(unsaturated) polyoxyalkylene polyether instead of the ",T-divinylsiloxane.
  • gels are not formed, and incorporation of silicone oil into the compositions must be performed using high shear kneading.
  • the products contain a high weight percentage of polyether moieties (ca 15% in the examples).
  • the synthesis must necessarily take place in several steps.
  • the additional step of kneading with silicone oil is disadvantageous.
  • the ",T-bis(unsaturated) polyethers are expensive to prepare.
  • U.S. Patent 5,811,487 describes low molecular weight siloxane fluids thickened with silicone elastomers prepared by reaction of Si-H functional siloxanes and an ",T-unsaturated diene hydrocarbon, the Si-H siloxane first having been partially reacted with a monoalkenyl functionalized polyether to provide polyether functionality.
  • the necessity of employing ",T-dienes is disadvantageous, as previously discussed.
  • U.S. Patent 5,854,336 discloses a process for preparing cosmetic products which involves feeding a silicone elastomer composition consisting of a silicone rubber and a carrier fluid into a reactor, mixing the composition in the reactor, delivering the composition from the reactor to a high pressure pump, and from there into a device for reducing the particles of rubber into smaller sizes.
  • the device for reducing particle size is preferably a high pressure feed homogenizer, most preferably a sonolator.
  • Use of high pressure pumps and devices such as sonolators increase the expense of the product.
  • Stable emulsions and creams containing water and glycols either cannot be prepared, or are difficult to prepare, due to the incompatibility of the hydrophobic silicone and hydrophilic water/glycols.
  • EP 0 790 055 A1 discloses compositions containing a partially reticulated elastomeric organopolysiloxane and a fatty component such as a triglyceride for use in skin care or make-up formulas. What is meant by “partially reticulated” is not defined in the specification, which refers to U.S. Patent 5,266,321 for its description of suitable organopolysiloxanes.
  • organopolysiloxane gels containing a low viscosity and preferably volatile silicone oil which can be emulsified with water and other hydrophilic liquids to form stable emulsions, may be easily prepared by the hydrosilylation reaction of an unsaturated MQ resin and an unsaturated hydrophile with an Si-H functional polyorganosiloxane in the presence of the low viscosity fluid and an effective amount of platinum hydrosilylation catalyst.
  • compositions which retain their stability over longer periods of time than when the organosulphur compounds are not employed.
  • organosulphur compounds particularly mercaptoalkyl-functional organopolysiloxanes
  • the resulting gels are ideally non-stringy gels which can be prepared in but one process step, and which may be easily homogenized to form a stable cream or paste without the use of high pressure or other complex mixing arrangements.
  • the gels can be emulsified with considerable quantities of water, or alcohols or glycols, for --example glycerine, ethylene glycol, and propylene glycol.
  • the present applications aims to provide for a stable organopolysiloxane gel obtainable by reacting a composition comprising:
  • the organopolysiloxane gels of the subject invention contain a low viscosity and preferably volatile silicone oil, intimately associated with a gel matrix produced by the cross-linking of a vinyl functional MQ resin with an Si-H functional organopolysiloxane which contains Si-H functionality distributed along its backbone rather than exclusively at the termini, in the presence of an effective amount of an unsaturated hydrophile, the latter preferably employed in the amount of from 0.2 to 5 weight percent.
  • the low viscosity and preferably volatile organopolysiloxane may be a low molecular weight oligomeric polydialkylsiloxane, or a cyclic siloxane.
  • the low viscosity organopolysiloxane is an oligomeric polydimethylsiloxane or a cyclic polydimethylsiloxane.
  • Other alkyl, aryl, alkaryl, and aralkyl groups are also acceptable, of course, for example, phenyl groups, benzyl groups, C 1 -C 18 alkyl groups, and the like.
  • organopolysiloxanes with methyl groups attached to the silicon atoms are highly preferred.
  • the organopolysiloxanes are linear trimethylsilyl terminated polydimethylsiloxanes having on average from 2 to 50 silicon atoms in the organopolysiloxane backbone inclusive of the trimethylsilyl end groups.
  • the number of silicon atoms should be greatly restricted, for example, to below 10, and preferably below 6.
  • extensions of the organopolysiloxane backbone to higher numbers of silicon atoms, for example, to 50 or 500 silicon atoms is possible.
  • These non-volatile fluids should have viscosities greater than 10 mm 2 /s, and up to 2000 mm 2 /s.
  • the organopolysiloxanes may also be slightly cross-linked, as long as the cross-linking does not overly increase the viscosity. Viscosity is preferably below 100 mm 2 /s, more preferably below 10 mm 2 /s, and most preferably, in the case of volatile organopolysiloxanes, less than 5 mm 2 /s.
  • the organopolysiloxanes are volatile organopolysiloxanes.
  • volatility can be achieved in linear organopolysiloxanes by selection of oligomeric organopolysiloxanes with at most 6 to 10 silicon atoms in the organopolysiloxane backbone.
  • cyclic organopolysiloxanes having from 3 to 6 silicon atoms are utilized, for example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodeca-methylcyclohexasiloxane, and the like.
  • groups other than methyl groups may be present, for example, C 1 -C 18 alkyl groups, preferably C 1-4 alkyl groups, aryl groups, and the like.
  • functional groups which do not interfere with the stability of the organopolysiloxane gels or with the ability to use these in cosmetic formulations may be tolerated.
  • examples include hydroxyl (silanol) groups, alkoxy groups, for example, those which are relatively hydrolytically stable, and the like.
  • oleaginous composition is used to describe the oily, hydrophobic component containing minimally 50 weight percent organopolysiloxane which is added during preparation of the gel. This composition does not include any additional oils which may be later added following preparation of the gel, by dissolution, emulsification, or dispersion prior to, concurrently with, or following emulsification of the -hydrophilic liquid(s), into the gel to form a hydrophilic liquid-containing emulsion.
  • Suitable oily substances include vitamin oils such as vitamins A or E or related compounds such as "-tocopheryl acetate; fatty oils, including T-3 and T-6 polyunsaturated fatty acids and their esters, retinol, retinoic acid, esters of the latter retin compounds; vegetable oils such as peanut, olive, palm, cannola, sunflower, and the like; mineral oils; flavoring or "essential” or “aromatic oils” such as the various terpenes both natural and synthetic, patchouli, myrrh, frankincense, lavender, vanillin, sandalwood, eucalyptus, camphor, menthol, and the like, or oily substances such as benzaldehyde, cinnamaldehyde, and the like; and natural and synthetic oils or oil-soluble solids such as various mono-, di- and triglycerides, polyoxyalkylated vegetable oils, lanolin, lecithin, and the like.
  • the oleaginous composition contains 70% or more low molecular weight, preferably volatile organopolysiloxanes, more preferably 80% or more, and most preferably 90% or more.
  • Oleophilic solvents particularly low odor paraffinic solvents which are pharmaceutically acceptable and have boiling points below 200°C, preferably in the range of 60°C to 150°C, may also be part of the oleaginous component in amounts of less than 30% by weight based on the total weight of this component.
  • a necessary component of the reaction mixture used to prepare the organopolysiloxane gel is a vinyl functional MQ resin or similar, highly crosslinked resin containing M, D, Q, and/or T moieties.
  • resins are by now well-known in the art.
  • the term "resin” is not applied to polymers in general, but is restricted for the use in describing relatively highly cross-linked and often high molecular weight products produced by the reaction of silanes which are capable of forming three-dimensional networks.
  • M refers to monofunctional units while the term Q refers to tetrafunctional units.
  • an MQ resin contains predominantly M units wherein silicon is attached to only one oxygen in the cross-linked molecules, and SiO 4/2 Q units wherein each silicon atom is attached to four other oxygen atoms, resulting in a high level of cross-linking.
  • small amounts of difunctional R 2 SiO 2/2 and trifunctional RSiO 3/2 are also present.
  • MQ resins are frequently produced by the hydrolysis of silanes such as tetraethoxysilane, vinyldimethylethoxysilane and trimethylethoxysilane.
  • MQ resin frequently retains some residual alkoxy functionality as a result of the method of its preparation, and will occasionally include other functionalities such as silanol functionality as well.
  • a preferred MQ resin is MQ resin 804, available from Wacker Silicones Corporation, Adrian, Michigan, which contains approximately 1.2 to 1.8 weight percent vinyl functionality. MQ resins having unsaturation other than vinyl, including vinyloxy, allyl, allyloxy, propenyl, etc., are less commonly available, but may be used also. The various unsaturated resins may be used alone or in admixture with other unsaturated resins. Minor amounts of unsaturated non-resinous organopolysiloxanes may be used as well, provided a stable gel can be obtained.
  • the Si-H functional organopolysiloxane cross-linking agent is a necessary part of the present gel formulation. While Si-H-terminated organopolysiloxanes may be used as crosslinkers, past experience indicates that gels may tend to have a stringy appearance. Allyl polyethers will react with the terminal Si-H groups thus acting like end-caps and inhibiting the crosslinking reaction. Theoretically, an excess of Si-H terminated silicones could form a gel. However a stringy gel without a high degree of three dimensional crosslinking would be expected.
  • the crosslinker must comprise, in substantial part, an Si-H functional organopolysiloxane which contains Si-H functional units along its polymer backbone.
  • the Si-H functional organopolysiloxane may or may not, in addition to these Si-H functional units, also include terminal Si-H units.
  • a preferred crosslinker is EL Crosslinker 525, a poly(methylhydrogen)-dimethylsiloxane containing approximately 0.54 weight percent silicon-bonded hydrogen atoms.
  • the crosslinkers preferably contain in excess of 5 Si-H bound hydrogens per molecule, more preferably 10 or more, and most preferably 20 or more. In addition to these highly Si-H functional crosslinkers, minor amounts, i.e., 50% or less or a weight basis, of lesser functional crosslinkers may be used.
  • the ratio of moles of unsaturation in the resin to moles of Si-H is preferably in the range of 0.4 to 2.0, more preferably 0.5 to 1.5, and most preferably 0.6 to 1.2. Ratios of 1.10 to 1.20 have proven quite satisfactory when MQ resins are employed.
  • An unsaturated hydrophile susceptible to hydrosilylation is also required.
  • the hydrophile is responsible for supplying compatibility with water and other relatively hydrophilic substances such as alcohols, glycols, and the like.
  • the unsaturation is preferably allylic, but may also be vinyl or in general, alkenyl. Examples of hydrosilylatable unsaturated moieties include, allyl, vinyl, (meth)acryloyl, allyloxy, vinyloxy, maleate, fumarate, and the like.
  • the hydrophilic function is supplied by a hydrophilic polyether group, or by polar groups such as hydroxyl groups, amide groups, carboxyl groups and their salts, etc.
  • the hydrophilic groups are non-ionic hydrophiles such as polyoxyalkylene groups, polyglycol moieties, oligosaccharides, and the like.
  • Polyoxyethylene groups are the preferred hydrophiles, particularly those containing four or more, preferably 4-50, and more preferably 5 to 20 repeating oxyethylene and/or oxypropylene groups, as well as those containing low numbers of oxypropylene groups may also be suitable.
  • the preferred hydrophiles correspond to the formula where R 1 is an unsaturated hydrocarbon, R is an alkylene group, particularly a C 1-5 alkylene group, preferably methylene, ethylene, methylethylene, 1,3-propylene or tetramethylene, and n is from 3 to 20.
  • Most preferred unsaturated hydrophiles correspond to the formula where R is defined as before and n is at least 3, preferably 4 and more preferably 5 and preferably not more than 50, preferably not more than 20, and more preferably not more than 12.
  • the distribution of alkylene groups when different alkylene moieties are present may be random, block, block-random, or any other distribution employed in polyether surfactants. Non-ionic hydrophiles are most preferred.
  • Preferred hydrophiles are prepared by oxyalkylating allyl alcohol in the presence of basic catalysts to form allyloxy-terminated, T-hydroxy polyether monols.
  • Allyloxy-functional polyoxyethylene monols are commercially available from Rhodia Inc. as Rhodasurf AAE-10 and from the Dow Chemical Company as AE-400. Both products are nominal five to ten mole oxyethylated allyl alcohol adducts containing a range of oligomers.
  • hydrophiles are oxyethylated unsaturated diols such as oxyethylated 1,4-butenediol and 1,4-butynediol, and oxyethylated unsaturated carboxylic acids, particularly T-alkenoic acids, or unsaturated diacids such as fumaric acid, maleic acid, and the like.
  • Hydrophiles with carboxylate ester end groups or alkyl ether end groups are also useful, particularly esters of lower C 2-4 alkanoic acids and ethers of lower C 1-4 alkanols.
  • Acetates and methoxy and ethoxy ethers are some preferred carboxylate and ether terminal groups.
  • the end groups may also be carboxylic acid groups, sulfonate groups, phosphanate groups, or their esters or salts. The same modifications may be made to other unsaturated hydrophiles.
  • alkenyl-functionalized polyhydroxy substances such as polyglycerols and oligosaccharides.
  • Polyglycerol for example, may be functionalized with allyl groups by reaction with allyl chloride to form the polyglycerol allyloxy ether, or with propenoic acid, propenoyl chloride, maleic acid, maleic anhydride, or maleic acid chloride to form the corresponding carboxylic acid ester(s). Syntheses for such compounds may be found in the literature. Functionalization may also be accomplished by reaction with unsaturated isocyanates such as 1-isocyanato-1,1-dimethyl-4-isopropenylbenzene (TMI) or isocyanatoethylmethacrylate.
  • TMI 1-isocyanato-1,1-dimethyl-4-isopropenylbenzene
  • Polyglycerols and oligosaccharides and similar hydrophiles may be modified to contain methoxy, ethoxy, carb
  • the amount of hydrophile must be sufficient to form a stable emulsion having the desired water/glycol content. For example, in general, less hydrophile content will be required when a 20% aqueous (water content) emulsion is to be formed than when a 30% aqueous emulsion is to be formed.
  • the amount will also depend upon the HLB of the hydrophile, and the number and nature of polar groups. For example, relatively larger quantities of low HLB oxyethylates such as the three mole oxyethylate of allyl alcohol will ordinarily be necessary as compared to the analogous 10 mole oxyethylate which has a much higher HLB.
  • Hydrophiles with large numbers of hydroxyl groups will ordinarily be required in lesser amounts than non-functional hydrophiles or hydrophiles with but a single polar functionality. Lesser amounts of hydrophiles or use of hydrophiles with lower HLB may be dictated when less polar liquids such as ethylene glycol, propylene glycol, 1,3-propanediol, or glycerine are to be emulsified into the gel. Mixtures of hydrophiles may be advantageous.
  • the amount of hydrophile is dependent upon the amount and nature of the substance-to be incorporated into the emulsion (water, propylene glycol, etc.), the amount of hydrophile is also tied to the amount and nature of the low viscosity organopolysiloxane which is also part of the gel.
  • large amounts of very hydrophilic (i.e., high HLB) or polar (i.e., polyhydroxyl) groups destabilize the organopolysiloxane gel.
  • the gel may become stringy, grainy, may solidify into a soft powder, or may itself separate. While stringy or grainy gels may at times be acceptable, soft or crumbly powders or solids or gels which exhibit separation are not.
  • the amount of hydrophile is often a compromise between the amount which can be tolerated in the organopolysiloxane gel initially formed, and the amount required to form a stable emulsion.
  • any given hydrophile is easily determined by preparation of a series of organopolysiloxane gels containing varying amounts of the hydrophile under consideration.
  • a stable gel indicates that the amount of hydrophile is sufficient for this purpose (gel formation), and testing for emulsion stability is then performed. If a stable emulsion containing the desired amount of polar solvent, i.e., 20 weight percent water, or 15 weight percent water and 10 weight percent propylene glycol, can be prepared, then the amount of hydrophile is an "effective compatibilizing amount" as herein defined. Note that both a stable organopolysiloxane gel as well as a stable emulsion must result. Organopolysiloxane gels which may be described by such terms as pasty, stringy, grainy, are suitable, provided that they are stable to separation and are capable of forming a smooth stable, emulsion with the desired quantity of polar solvent.
  • the gels themselves be smooth gels. Reaction of Si-H terminated polysiloxanes and unsaturated organopolysiloxane in the absence of unsaturated hydrophiles has been demonstrated in the past to produce only stringy gels.
  • a preferred hydrophile amounts of less than 0.3 weight percent hydrophile based on the weight of the organopolysiloxane gel are generally not suitable for forming stable emulsions from greater than 10-15 weight percent water. Amounts of 0.6 weight percent have proven highly suitable for preparing emulsions containing up to 40-50 weight percent of water, or 30 weight percent propylene glycol. Most preferably, the minimum amount of unsaturated hydrophile is 0.1 weight percent based on the total weight of the gel. Amounts of 2 weight percent or more of this hydrophile have been found to cause instability of the organopolysiloxane gel. With respect to the gel itself, a gel is considered within the scope of the intention if it can form a stable emulsion with a greater amount of hydrophilic liquid than a similar gel prepared from a composition containing no unsaturated hydrophile.
  • hydrophobes of differing HLB may be useful in preparing gels which are stable and yet contain larger quantities of hydrophile.
  • polyoxypropylated allyl alcohol is much less hydrophilic than its polyoxyethylated analog.
  • polyoxypropylene groups do not become - hydrophobic until their molecular weight reaches the neighborhood of 500 Daltons (Da).
  • the use of less hydrophilic polyoxypropylates of allyl alcohol together with a more hydrophilic hydrophile such as an allyloxy polyglycerol, allyloxy oligosaccharide, or polyoxyethylated allyl alcohol may provide both high gel stability as well as high emulsion stability.
  • broad or bimodal distributions of polyoxyalkylated allyl alcohol oligomers may provide similar benefits.
  • hydrosilylation catalyst is also required.
  • Suitable hydrosilylation catalysts are well-known, and widely available from numerous sources.
  • Preferred hydrosilylation catalysts are platinum compounds such as those disclosed in U.S. Patents 3,159,601; 3,159,662; 3,220,972; 3,715,334; 3,775,452; and 3,814,730, and German published application DE 195 36176 A1, preferably supplied in a solvent suitable for use in cosmetic formulations, such as propanediol.
  • Catalyst OL a divinyl-terminated polydimethylsiloxane platinum complex diluted with polydimethylsiloxane, and available from Wacker Silicones, Adrian, Michigan.
  • Other solvents may be used as well for dilution of the catalyst, provided that they are cosmetically acceptable, or can be removed from the gel, for example, by exposure to low pressures or stripping.
  • compositions contain from 60% to 90% oleaginous composition, from 5% to 25% unsaturated resin, and from 1% to 8% Si-H functional crosslinker.
  • compositions contain from 60 to 85% by weight oleaginous composition, 10 to 20% unsaturated resin, and 1 to 5% crosslinker.
  • Compositions containing 75-80% organopolysiloxane, 15-20% vinyl-functional resin, and 2-3% crosslinker have proven exceptionally useful. These percentages are percentages by weight based on the total weight of the gel, and are based on an MQ resin having 1.2 to 1.8 weight percent vinyl functionality and a crosslinker containing 0.5 weight percent Si-H bound hydrogen distributed predominately along the polysiloxane chain. Resins and crosslinkers with higher functionalities may be used in lesser amounts and vice versa. The functionality must not be too high, or a solid, too highly crosslinked product may be obtained. The amount, functionality, and molecular weight of the MQ resin and Si-H crosslinker may be easily determined by one skilled in the art.
  • the preparation of the gel is readily accomplished. In general, all of the ingredients except the catalyst are added and stirred slowly until a homogenous mixture is obtained, following which the catalyst is added with continual stirring.
  • the hydrophile is preferably added last before the catalyst.
  • the composition can be left at room temperature until a gel is formed, or can be heated. Preferably, the composition is heated to a temperature between 50°C and 100°C, more preferably between 60°C and 90°C until the mixture solidifies or gels. The 90 to 100°C range is preferred with Pt/propandiol, but temperatures of approximately 60°C are preferred with Catalyst OL.
  • Gelation typically takes place within several minutes to five hours, preferably within a maximum of three hours, and typically in a half hour.
  • the gel is then homogenized to a smooth consistency using standard high shear mixing techniques such as the use of an Ultra-TuraxTM mixer or the like. High pressure mixing and recirculated mixing techniques are not necessary, although they may be practiced if
  • ком ⁇ онентs such as perfumes, emollients, lanolin, oils, pigments, U.V. absorbers, dyes, etc.
  • Thickeners such as pyrogenic silica and other ingredients may also be added at this point to increase the viscosity of the cream to form paste-like products.
  • the hydrophilic liquid may be added prior to or after the addition of these other ingredients to form the emulsions of the subject invention.
  • cosmetic ingredients which may be added is not overly critical, and can be easily selected by one skilled in the art.
  • cosmetically acceptable ingredients includes all ingredients which can be added by a cosmetic formulator which are cosmetically acceptable for use on the skin. Many such ingredients are listed in standard references, for example International Cosmetic Ingredient Dictionary And Handbook, ⁇ 1997, Cosmetic, Toiletry and Fragrance Assoc., Washington, D.C.
  • Suitable fillers include all those commonly employed. All or part of the filler may be added prior to gelation; however, it is highly preferred to form the gel first and to add filler with stirring to obtain a homogenous-appearing mixture.
  • Examples of fillers include fumed or pyrogenic silica, precipitated silica, other silaceous fillers, and in particular silaceous fillers having a BET surface area greater then 50 m 2 /g; metal silicates, particularly those containing metals of Groups 1 and 2 of the periodic table; diatomaceous earth; precipitated calcium carbonate; fuller's earth; clay minerals, e.g., smectite clays, including bentonite, wollastonite, etc.; kieselguhr; chalk; transparent iron oxides, and the like.
  • Fillers which are colored can be simultaneously used as pigments herein. Fillers may preferably be employed in amounts of 0.05 to 40 weight percent, more preferably 0.1 to 25 weight percent, and most preferably 0.5 to 10 weight percent. Fillers of high surface area are generally used in lesser amounts than low surface area fillers, due to the viscosity-increasing effect of the former.
  • gel stability As indicated previously, two types of stability are referred to herein: gel stability and emulsion stability. Both are somewhat similarly assessed. Gel quality may be qualitatively assessed by observation of the texture of the gel after high shear mixing. Most preferably, the gel thus produced is a smooth, creamy, non-stringy lotion, cream, or paste. While such uniform products are preferable, products which are somewhat stringy, or grainy (e.g., applesauce-like in texture), while less desirable, may also be suitable provided they are stable and form stable emulsions as well. -
  • Stability of the gel is preferably assessed visually after long term storage, however a quicker but qualitative assessment is by centrifugation.
  • a lotion, cream, or paste produced_by shearing the gel which is stable against more than minor separation after two months storage at room temperature, is considered stable.
  • a minor amount of separation is observed where a small amount of liquid separates from the emulsion. Separated liquid can generally be found at the bottom or the top of the lotion, cream, or paste depending upon the relative densities of the components.
  • no phase separation is visible for two months, and most preferably for a year or more.
  • the lotion, cream, or paste gel product may also be centrifuged in a standard laboratory centrifuge using 50 g sample cups. A rotational speed of 2000 rpm is suitable. Separation may be recorded in ml. Preferably, the amount of separation after one hour is less than 1 ml, more preferably less than 0.5 ml, and yet more preferably less than 0.1 ml. No separation is most preferred. However, it must be remembered that centrifugation is a somewhat extreme test, and compositions with moderate separation, i.e., 1-3 ml, may still be suitable if separation does not occur at room temperature in non-centrifuged samples over a long period of time. Centrifugation is a rapid means of assessment which is not always definitive.
  • a hydrophilic liquid-containing emulsion is stable following preparation if the emulsion has a smooth consistency and does not display phase separation under room temperature storage.
  • emulsions which are grainy or stringy are not suitable in the present invention.
  • Emulsions may be clear, translucent, opaque, or pearlescent, but should be smooth and uniform.
  • the centrifuge test may be used to screen emulsions, as with the gels. However, as with the gels, long term storage stability rather than passing any given centrifuge stability test, is the object.
  • the gels produced herein generally and preferably have a % polysiloxane solids of from 15 to 25%, a flash point of 50°C (122°F) or higher, a specific gravity just under 1.0, for example between 0.92 and 0.98, a Brookfield viscosity (spindle 6, 5 rpm or 8.3 x 10 -2 s -1 ) of 80,000 to 150,000 mPas, preferably 100,000 to 120,000 mPas, and a texture hardness at 20 mm (g) of 15-30, preferably 20.
  • the gels preferably exhibit a water "solubility" (stable emulsion) of up to 50% by weight based on total emulsion weight, preferably in the range of 20-40%, and a propylene glycol "solubility" (stability) of more than 10%, preferably in the range of 20% to 40%.
  • water “solubility” stable emulsion
  • propylene glycol "solubility" stable emulsion
  • the creamy gels of the subject invention may be used in all cosmetic formulations where silicone emulsions and other products have been used in the past, including, without limitation, skin care products such as antiperspirants, deodorants, sun care, after sun care, moisturizers, creams and lotions; color cosmetic products, such as facial powder, eye powder, eye shadow, liquid foundation, liquid-to-powder foundations, and lipsticks; and hair care products such as hair conditioners, volume enhancers, and the like.
  • skin care products such as antiperspirants, deodorants, sun care, after sun care, moisturizers, creams and lotions
  • color cosmetic products such as facial powder, eye powder, eye shadow, liquid foundation, liquid-to-powder foundations, and lipsticks
  • hair care products such as hair conditioners, volume enhancers, and the like.
  • the overall procedure followed for gel preparation is as follows: In general, a 500 ml flask equipped with desiccator-capped condenser, heating mantle, metal stirrer with bearing, and temperature controller, is charged with unsaturated MQ resin, Si-H crosslinker, and oleaginous composition, and homogenized by stirring. In general, a true solution of these ingredients will be formed, although this is not necessary. The unsaturated hydrophile is then added slowly with stirring, lump formation being avoided if at all possible. While stirring at 5 s -1 , the catalyst solution is added, and the mixture heated until gel formation is observed. Heating is preferably limited so as to keep the temperature below 100°C.
  • the temperature ranged from ambient to about 90°C over a period of about 25 minutes. Following gelation, heating may be discontinued, but is preferably continued for about 30 minutes to achieve higher completion of the crosslinking reaction.
  • the product is cooled to 40°C and inhibitor (if used) added.
  • the product is then homogenized to a creamy gel using an Ultra Turrax® mixer. Appropriate physical measurements are taken as desired, and stability is assessed. Larger batches, of course, require a larger reaction vessel. In the Examples and tables, all percentages are in weight percent unless indicated otherwise.
  • organopolysiloxane gels were prepared in accordance with the procedure outlined previously, employing decamethylcyclopentasiloxane, a volatile cyclic siloxane, as the low viscosity oleaginous fluid.
  • the catalyst employed in Comparative Example C1 and Examples 2-5 is a 2.94 weight percent solution of hexachloroplatinic acid in 1,2-propanediol.
  • the catalyst employed in Examples 6-8 is Catalyst OL, a platinum catalyst available from Wacker Silicones, Adrian, Michigan.
  • the polyglycol used in Examples 1-5 is DowTM AE-400, while Examples 6-8 employed RhodasurfTM AE-10.
  • Examples 1-8 all produced suitable gels, exhibiting acceptable stability in all cases.
  • the gels of Examples 2,4, and 5 were not optimally creamy, but showed no evidence of separation.
  • Examples 1, 3, 6, 7, and 8 all produced uniform, creamy gels.
  • Examples 7 and 8 were produced in larger batch sizes following the same procedure, to partially assess commercial producibility which would be performed at yet higher volume.
  • Comparative Example C1 produced a creamy gel. However, this gel contained no unsaturated hydrophile component. As a result, while suitable for some uses, it cannot be used to form a stable emulsion with any significant amount of water or other hydrophilic liquid without the addition of emulsifying surfactants which are undesirable in many cosmetic formulations.
  • the gels of the subject invention are all capable of forming stable emulsions with greater quantities of hydrophillic liquids than otherwise similar gels prepared without the unsaturated hydrophile component. It is preferred that the gels be suitable for use with minimally 5% by weight hydrophilic liquid, more preferably minimally 10% by weight, and yet more preferably minimally 15% by weight.
  • Example 7 The organopolysiloxane gel of Example 7 was employed to form hydrophilic liquid-containing emulsions. To a quantity of gel was added sufficient water to form 5% to 50% water content emulsions. The water was slowly sheared into the gel using an Ultra-Turrax® mixer at ambient temperature. The compositions and results are presented in Table 2.
  • Example 9 10 11 12 13 C14 Organopolysiloxane gel (g) 380 360 320 280 240 200 water (g) 20 40 80 120 160 200 weight percent water 5% 10% 20% 30% 40% 50% Emulsion Formed?
  • Example 13 exhibit any separation, and that separation is slight and acceptable for most uses though not desirable. Even at this high level of water incorporation, fine tuning of hydrophile type and/or amount should be able to produce an organopolysiloxane gel which can produce a more stable emulsion. Comparative Example C14 would not emulsify at 50% water. While the gel used in this Comparative Example is a gel of the subject invention, the water-containing composition, forming no stable emulsion, is not.
  • hydrophile For greater compatibility with propylene glycol, it may be necessary to modify the amount of gel-bound hydrophile, to use a different hydrophile, e.g., a polyoxypropylene analog of the polyoxyethylene hydrophiles of the examples, or use two or more different hydrophiles.
  • a different hydrophile e.g., a polyoxypropylene analog of the polyoxyethylene hydrophiles of the examples, or use two or more different hydrophiles.
  • organopolysiloxane gels were prepared employing BimaxTM AAP-10, a polyoxypropylated - allyl alcohol containing nominally 10 oxypropylene moieties, and having a 2.87 weight percent "vinyl" (allyl) content.
  • the reactions were performed in a 500 mL kettle with desiccator-capped condenser, heating mantle, metal stirrer with bearing, and temperature controller.
  • the silicon compounds and polyether were added and stirred at 300 rpm (5 s -1 ) followed by addition of catalyst. The mixture was heated to 65°C and stirred until gel formation occurred.
  • Example: 20 21 22 Ingredients: (g) D5 Cyclosiloxane 316 314 310 MQ Resin 804 71.8 71.8 72.0 Crosslinker 525 8.0 8.0 8.0 Bimax AAP-10 2.5 4.0 8.0 Catalyst OL 0.20 0.20 0.20 F950A 1.20 1.60 1.60 Polyglycol % by Weight 0.617 1.00 2.00 Characteristics: Viscosity (mPas) 84,000 82,500 24,000 Appearance creamy gel creamy gel liquidy %H (final) 0.0019 0.0026 0.0025 Flash point, °C 69.4 72.2 70.0 Texture 20 mm (g) 11 12 not measured
  • Ethylene glycol emulsions were prepared from organosiloxane gels of the subject invention. Ethylene glycol was slowly blended into a gel prepared in accordance with Example 8, containing 0.3 weight percent of a 10 mol adduct of ethylene oxide onto allyl alcohol. Compositions containing 10% and 30% ethylene glycol (Examples 23, 24) were very stable, exhibiting no separation even after 1 hour of centrifuging at 2000 rpm. Compositions containing 40% and 55% by weight ethylene glycol (Examples 25, 26) were also quite stable, exhibit only a small "bubble" of separated liquid after centrifuging. All the preparations exhibited a nice, creamy feel. The respective viscosities were 74,000 mPas, 123,000 mPas, 126,000 mPas, and 136,000 mPas.
  • hydrosilylation-type gels may be maintained over time if a minor, but effective amount of a hydrosilylation catalyst inhibitor is added to the formulation, preferably after initial gelation.
  • a hydrosilylation catalyst inhibitor When such inhibitors are added prior to or during hydrosilylation, the catalyst level must generally be increased somewhat, even though the hydrosilylation reaction has been largely completed at this point. Addition of such inhibitors can also generate useful gels from compositions which, if fully crosslinked, would be too highly crosslinked. Thus, the optional inhibitor component broadens the range of useful crosslinkable compositions.
  • the catalyst inhibitors may be selected from all hydrosilylation catalyst inhibitors available. However, because the gels are intended for cosmetic formulations, some inhibitors may not be advisable for toxicological reasons, or for customer acceptance. For example, compounds such as dodecanethiol should be avoided due to its odor. However, in perfume-laden cosmetics, or where very small amounts are used, even these inhibitors may be acceptable.
  • the amount of inhibitor generally ranges from 0.001 to 2 parts by weight, preferably 0.01 part to 1 part by weight based on a total gel weight of 100 parts. More preferably, 0.1 part to 0.8 part, and most preferably 0.2 part to 0.5 parts are used. The amount is preferably sufficient such that no or only very little noticeable increase in hardness occurs over a two week period of storage at room temperature. While the inhibitors are preferably added following gelation, or following the onset of gelation, the inhibitor may be added at the same time or even before catalyst addition. Additional catalyst may be required in such cases.
  • ingredients used and exemplified herein are considered individually disclosed, and may be used to exclusion of any other ingredient identified herein or not disclosed herein, so long as the necessary ingredients are employed, and a stable gel, and stable emulsion at the target hydrophilic liquid content prepared from the gel are obtained.
  • Necessary ingredients for the organopolysiloxane gets of the present invention are a low viscosity organopolysiloxane, an unsaturation-functional MQ resin, an SiH functional crosslinker, an unsaturated, hydrosilylatable hydrophile, and a hydrosilylation catalyst.
  • Necessary ingredients of the emulsions of the present invention are an organopolysiloxane gel as previously described, and at least one hydrophilic liquid which forms a smooth, stable emulsion in the gel at a given target concentration.
  • the terms “a” and “an” mean one or more than one unless indicated otherwise.
  • incompatible hydrophillic liquid is meant a liquid which will not form a stable emulsion at the same weight/weight concentration in a gel formed from the same components but without the incorporation of the hydrosilylatable unsaturated hydrophile component into the organopolysiloxane gel.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Silicon Polymers (AREA)
EP01101608A 2000-03-10 2001-01-25 Organopolysiloxane gels for use in cosmetics Expired - Lifetime EP1132430B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US522480 2000-03-10
US09/522,480 US6365670B1 (en) 2000-03-10 2000-03-10 Organopolysiloxane gels for use in cosmetics

Publications (2)

Publication Number Publication Date
EP1132430A1 EP1132430A1 (en) 2001-09-12
EP1132430B1 true EP1132430B1 (en) 2005-11-02

Family

ID=24081032

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01101608A Expired - Lifetime EP1132430B1 (en) 2000-03-10 2001-01-25 Organopolysiloxane gels for use in cosmetics

Country Status (6)

Country Link
US (1) US6365670B1 (ru)
EP (1) EP1132430B1 (ru)
JP (1) JP4280427B2 (ru)
CA (1) CA2340498C (ru)
DE (1) DE60114488T2 (ru)
RU (1) RU2205624C2 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101825860B1 (ko) 2013-12-17 2018-02-05 와커 헤미 아게 글리코시드기를 갖는 폴리유기실록산 겔

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050033132A1 (en) 1997-03-04 2005-02-10 Shults Mark C. Analyte measuring device
US6001067A (en) 1997-03-04 1999-12-14 Shults; Mark C. Device and method for determining analyte levels
US7192450B2 (en) 2003-05-21 2007-03-20 Dexcom, Inc. Porous membranes for use with implantable devices
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
AU2002309528A1 (en) 2001-04-02 2002-10-15 Therasense, Inc. Blood glucose tracking apparatus and methods
US6538061B2 (en) * 2001-05-16 2003-03-25 General Electric Company Cosmetic compositions using polyether siloxane copolymer network compositions
US20030203978A1 (en) * 2001-05-16 2003-10-30 O'brien Michael Joseph Cosmetic compositions comprising silicone gels comprising entrapped, occluded or encapsulated pigments
US20030032874A1 (en) 2001-07-27 2003-02-13 Dexcom, Inc. Sensor head for use with implantable devices
US6702857B2 (en) 2001-07-27 2004-03-09 Dexcom, Inc. Membrane for use with implantable devices
US6716908B2 (en) * 2002-01-30 2004-04-06 Dow Corning Corporation Alkoxysilyl functional silicone based materials
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US6881416B2 (en) * 2002-04-08 2005-04-19 Wacker Chemical Corporation Alkyl group-substituted organopolysiloxane gels
US7226978B2 (en) 2002-05-22 2007-06-05 Dexcom, Inc. Techniques to improve polyurethane membranes for implantable glucose sensors
US20060258761A1 (en) * 2002-05-22 2006-11-16 Robert Boock Silicone based membranes for use in implantable glucose sensors
GB0212324D0 (en) * 2002-05-29 2002-07-10 Dow Corning Silicon composition
JP4490817B2 (ja) * 2002-09-12 2010-06-30 信越化学工業株式会社 新規なオルガノポリシロキサン重合物及びペースト状組成物並びにその組成物を用いた化粧料
GB0300808D0 (en) * 2003-01-14 2003-02-12 Unilever Plc Home and personal care compositions with lubricants
US7134999B2 (en) * 2003-04-04 2006-11-14 Dexcom, Inc. Optimized sensor geometry for an implantable glucose sensor
US7875293B2 (en) 2003-05-21 2011-01-25 Dexcom, Inc. Biointerface membranes incorporating bioactive agents
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US20050056552A1 (en) * 2003-07-25 2005-03-17 Simpson Peter C. Increasing bias for oxygen production in an electrode system
JP4708342B2 (ja) 2003-07-25 2011-06-22 デックスコム・インコーポレーテッド 埋設可能な装置に用いる酸素増大膜システム
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US8676287B2 (en) 2003-08-01 2014-03-18 Dexcom, Inc. System and methods for processing analyte sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7045586B2 (en) * 2003-08-14 2006-05-16 Dow Corning Corporation Adhesives having improved chemical resistance and curable silicone compositions for preparing the adhesives
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US20050090607A1 (en) * 2003-10-28 2005-04-28 Dexcom, Inc. Silicone composition for biocompatible membrane
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
WO2005057168A2 (en) 2003-12-05 2005-06-23 Dexcom, Inc. Calibration techniques for a continuous analyte sensor
EP1711791B1 (en) 2003-12-09 2014-10-15 DexCom, Inc. Signal processing for continuous analyte sensor
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2009048462A1 (en) 2007-10-09 2009-04-16 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8277713B2 (en) 2004-05-03 2012-10-02 Dexcom, Inc. Implantable analyte sensor
WO2006127694A2 (en) 2004-07-13 2006-11-30 Dexcom, Inc. Analyte sensor
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US20060020192A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US20060016700A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
EP1901709A2 (en) * 2005-06-10 2008-03-26 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
US7452957B2 (en) 2005-08-31 2008-11-18 Kimberly-Clark Worldwide, Inc. Hydrophilic silicone elastomers
US7767754B2 (en) 2005-11-08 2010-08-03 Momentive Performance Materials Inc. Silicone composition and process of making same
US7479522B2 (en) * 2005-11-09 2009-01-20 Momentive Performance Materials Inc. Silicone elastomer composition
EP3513708B1 (en) * 2006-03-09 2022-12-28 Dexcom, Inc. Systems and methods for processing analyte sensor data
JP5199231B2 (ja) 2006-03-21 2013-05-15 ダウ・コーニング・コーポレイション シリコーンポリエーテルエラストマーゲル
JP5424866B2 (ja) * 2006-03-21 2014-02-26 ダウ・コーニング・コーポレイション シリコーンポリエーテルエラストマーゲル
KR101364818B1 (ko) 2006-03-21 2014-02-19 다우 코닝 코포레이션 실리콘 엘라스토머 겔
GB0610622D0 (en) * 2006-05-31 2006-07-05 Dow Corning Process for making and using foam control compositions
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
FR2910316A1 (fr) * 2006-12-20 2008-06-27 Oreal Procede de demaquillage des cheveux recouverts d'un film polymere particulier
EP2114366A2 (en) * 2006-12-29 2009-11-11 Dow Corning Corporation Personal care compositions containing silicone elastomer gels
US20200037875A1 (en) 2007-05-18 2020-02-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US20080306444A1 (en) 2007-06-08 2008-12-11 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
WO2009042732A1 (en) * 2007-09-26 2009-04-02 Dow Corning Corporation Personal care compositions containing hydrophobic silicone-organic gel blends
KR20100061699A (ko) 2007-09-26 2010-06-08 다우 코닝 코포레이션 유기폴리실록산 수지로부터의 실리콘 유기 엘라스토머 겔
CN101808610B (zh) 2007-09-26 2013-08-28 陶氏康宁公司 含来自聚氧化烯交联的硅氧烷弹性体的硅氧烷-有机凝胶的个人护理组合物
CA2715628A1 (en) 2008-02-21 2009-08-27 Dexcom, Inc. Systems and methods for processing, transmitting and displaying sensor data
US8241616B2 (en) * 2008-04-03 2012-08-14 Rohm And Haas Company Hair styling composition
GB0811302D0 (en) * 2008-06-20 2008-07-30 Dow Corning Shampoo compositions
DE102008032066A1 (de) * 2008-07-08 2010-01-14 Byk-Chemie Gmbh Polyhydroxyfunktionelle Polysiloxane als anti-adhäsive und schmutzabweisende Zusätze in Beschichtungen, polymeren Formmassen und Thermoplasten, Verfahren zu ihrer Herstellung und ihre Verwendung
GB0813140D0 (en) * 2008-07-18 2008-08-27 Dow Corning Home and personal care compositions
US9801575B2 (en) 2011-04-15 2017-10-31 Dexcom, Inc. Advanced analyte sensor calibration and error detection
AU2010208627A1 (en) * 2009-01-28 2011-09-15 Alzo International, Inc. Hydrophilic silicone elastomers in cosmetics
EP2464428A2 (en) 2009-08-13 2012-06-20 Dow Corning Corporation Granulated dry cleanser for the care of keratinous substrates
CN103443208A (zh) 2011-03-28 2013-12-11 道康宁公司 固体染色组合物
FR2974367B1 (fr) * 2011-04-22 2013-05-24 Oreal Compositions comprenant un polymere a motif dendrimere carbosiloxane et une quantite elevee de mono-alcool
DE102012206209A1 (de) * 2012-04-16 2013-10-17 Wacker Chemie Ag Organopolysiloxangele
WO2014081950A2 (en) 2012-11-21 2014-05-30 Dow Corning Corporation Fabric care compositions comprising emulsions
JP6189593B2 (ja) * 2012-12-28 2017-08-30 東レ・ダウコーニング株式会社 透明乃至半透明の液状のグリセリン誘導体変性架橋シリコーン組成物の製造方法
EP3063208B1 (en) 2013-10-31 2017-10-18 Dow Corning Corporation Cross-linked composition and method of forming the same
EP3063227B1 (en) 2013-10-31 2020-09-02 Dow Silicones Corporation Cross-linked composition and method of forming the same
US10092780B2 (en) 2013-10-31 2018-10-09 Dow Silicones Corporation Cosmetic composition comprising a carboxy-functional elastomer
DE102013226249A1 (de) * 2013-12-17 2015-06-18 Wacker Chemie Ag Polyetherreste aufweisende Organopolysiloxangele
US9833402B2 (en) * 2014-01-27 2017-12-05 Conopco, Inc. Composition
US20150274970A1 (en) * 2014-03-26 2015-10-01 Wacker Chemical Corporation Control of internal viscosity in in situ polymerized organopolysiloxane emulsions
JP6387885B2 (ja) * 2015-04-06 2018-09-12 信越化学工業株式会社 剥離紙又は剥離フィルム用オルガノポリシロキサンエマルション組成物及びその製造方法、並びに剥離紙及び剥離フィルム
CN106317894B (zh) * 2015-06-30 2019-03-29 比亚迪股份有限公司 有机硅组合物、反光涂层及其制备方法与包括其的光伏组件
EP3429554A1 (en) 2016-03-14 2019-01-23 Dow Silicones Corporation Composition and method of preparation
CN110709744B (zh) * 2017-06-06 2021-09-10 康普技术有限责任公司 具有自修复折光指数匹配凝胶的光学纤维对准装置
US11654098B2 (en) * 2017-06-12 2023-05-23 Wacker Chemie Ag Process for preparing organopolysiloane gels
WO2019083939A1 (en) 2017-10-24 2019-05-02 Dexcom, Inc. PRECONNECTED ANALYTE SENSORS
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
EP3806818B1 (en) 2018-12-29 2021-11-24 Wacker Chemie AG Hydrophilic cyclodextrin-containing silicone gels
WO2020139404A1 (en) 2018-12-29 2020-07-02 Wacker Chemie Ag Cyclodextrin modified silicone composition
WO2020153938A1 (en) 2019-01-22 2020-07-30 Wacker Chemie Ag Hydrocarbon-containing organopolysiloxane gel
US11603435B2 (en) 2019-02-18 2023-03-14 Dow Silicones Corporation Hydrophilic polysiloxane elastomer
JP2023537566A (ja) 2020-06-24 2023-09-04 ワッカー ケミー アクチエンゲゼルシャフト 湿気硬化性コンフォーマルコーティング組成物
KR20230143852A (ko) * 2022-04-06 2023-10-13 주식회사 케이씨씨실리콘 폴리실록산 조성물 및 이로부터 제조된 친수성 실리콘

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159601A (en) 1962-07-02 1964-12-01 Gen Electric Platinum-olefin complex catalyzed addition of hydrogen- and alkenyl-substituted siloxanes
US3220972A (en) 1962-07-02 1965-11-30 Gen Electric Organosilicon process using a chloroplatinic acid reaction product as the catalyst
US3159662A (en) 1962-07-02 1964-12-01 Gen Electric Addition reaction
US3814730A (en) 1970-08-06 1974-06-04 Gen Electric Platinum complexes of unsaturated siloxanes and platinum containing organopolysiloxanes
US3715334A (en) 1970-11-27 1973-02-06 Gen Electric Platinum-vinylsiloxanes
US3775452A (en) 1971-04-28 1973-11-27 Gen Electric Platinum complexes of unsaturated siloxanes and platinum containing organopolysiloxanes
JPS5968333A (ja) 1982-10-12 1984-04-18 Toray Silicone Co Ltd 線状オルガノポリシロキサンブロツクを含有するポリマもしくはポリマ組成物の球状硬化物およびその製造方法
US4806430A (en) 1985-12-03 1989-02-21 Becton, Dickinson And Company Film-forming silicone compositions having lubricating properties
JPS62243621A (ja) 1986-04-17 1987-10-24 Toray Silicone Co Ltd シリコ−ンゴム粒状物の製造方法
US5266321A (en) 1988-03-31 1993-11-30 Kobayashi Kose Co., Ltd. Oily make-up cosmetic comprising oil base and silicone gel composition
JPH0655897B2 (ja) 1988-04-22 1994-07-27 信越化学工業株式会社 シリコーン組成物の製造方法
JPH0753646B2 (ja) 1989-01-31 1995-06-07 東レ・ダウコーニング・シリコーン株式会社 化粧料
JPH0660286B2 (ja) 1989-02-15 1994-08-10 信越化学工業株式会社 油性ペースト組成物
US5219560A (en) * 1989-03-20 1993-06-15 Kobayashi Kose Co., Ltd. Cosmetic composition
US5136068A (en) 1989-04-26 1992-08-04 Dow Corning Corporation Cross-linked organopolysiloxanes and emulsions based thereon
EP0398745B1 (en) 1989-05-19 1996-09-04 Shin-Etsu Chemical Co., Ltd. Curable silicone compositions
JP2631772B2 (ja) 1991-02-27 1997-07-16 信越化学工業株式会社 新規なシリコーン重合体及びそれを用いた水分散能を有するペースト状シリコーン組成物
DE4129613A1 (de) 1991-09-06 1993-03-11 Wacker Chemie Gmbh Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse
EP0545002A1 (en) 1991-11-21 1993-06-09 Kose Corporation Silicone polymer, paste-like composition and water-in-oil type cosmetic composition comprising the same
US5599533A (en) 1994-12-15 1997-02-04 Estee Lauder, Inc. Stable water-in-oil emulsion system
FR2744911B1 (fr) 1996-02-19 1998-03-20 Oreal Utilisation d'un organopolysiloxane solide elastomere associe a une phase grasse pour la preparation d'une composition ou dans une composition de soin ou de maquillage pour matifier la peau
US5654362A (en) 1996-03-20 1997-08-05 Dow Corning Corporation Silicone oils and solvents thickened by silicone elastomers
US5919437A (en) 1996-05-24 1999-07-06 Colgate-Palmolive Company Cosmetic cream composition containing silicone gel material
ZA971943B (en) 1996-06-28 1998-09-07 Unilever Plc Vitamin C delivery system
US5833973A (en) 1996-06-28 1998-11-10 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Crosslinked elastomeric silicones in aqueous emulsion cosmetic compositions
US5853741A (en) 1996-06-28 1998-12-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Vitamin C delivery system
US6074672A (en) 1996-06-28 2000-06-13 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Powdered cosmetic compositions containing silicone elastomers
US5760116A (en) 1996-09-05 1998-06-02 General Electric Company Elastomer gels containing volatile, low molecular weight silicones
DE69732464T2 (de) 1996-10-03 2006-05-11 Shiseido Co. Ltd. Äusserliches gelförmiges Hautpflegemittel
GB9622580D0 (en) 1996-10-30 1997-01-08 Unilever Plc Antiperspirant composition
US5811487A (en) 1996-12-16 1998-09-22 Dow Corning Corporation Thickening silicones with elastomeric silicone polyethers
US5854336A (en) 1997-03-20 1998-12-29 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Process for preparing silicone elastomer compositions
US5889108A (en) 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers
US6013711A (en) 1997-06-18 2000-01-11 Ck Witco Corporation Hydrophilic polysiloxane compositions
US6083901A (en) * 1998-08-28 2000-07-04 General Electric Company Emulsions of fragrance releasing silicon compounds
US6171581B1 (en) * 1998-12-18 2001-01-09 Revlon Consumer Products Corporation Water and oil emulsion solid antiperspirant/deodorant compositions
US6423322B1 (en) 1999-05-22 2002-07-23 Wacker Silicones Corporation Organopolysiloxane gels for use in cosmetics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101825860B1 (ko) 2013-12-17 2018-02-05 와커 헤미 아게 글리코시드기를 갖는 폴리유기실록산 겔

Also Published As

Publication number Publication date
JP2001261835A (ja) 2001-09-26
DE60114488D1 (de) 2005-12-08
US6365670B1 (en) 2002-04-02
CA2340498A1 (en) 2001-09-10
CA2340498C (en) 2006-10-03
JP4280427B2 (ja) 2009-06-17
DE60114488T2 (de) 2006-04-27
EP1132430A1 (en) 2001-09-12
RU2205624C2 (ru) 2003-06-10

Similar Documents

Publication Publication Date Title
EP1132430B1 (en) Organopolysiloxane gels for use in cosmetics
EP1057476B1 (en) Organopolysiloxane gels for use in cosmetics
EP1352926B1 (en) Alkyl group-substituted organopolysiloxane gels
KR101864579B1 (ko) 모노- 또는 디-글리세린 유도체 변성 오르가노폴리실록산 엘라스토머 및 그 이용
JPS6336620B2 (ru)
JP6143681B2 (ja) 二峰性エマルジョン
JP4160165B2 (ja) ポリオルガノシロキサンエマルジョンおよびそれを用いる化粧料
JP2010144157A (ja) 乳化物、その製造方法および該乳化物からなる化粧料原料
JP5430142B2 (ja) 乳化物の製造方法
TW200301136A (en) Stabilization of vitamins in water-in-silicone oil (W/O) emulsions
JP2903247B2 (ja) 油中水型乳化組成物
US20040214977A1 (en) Amphiphilic organopolysiloxanes having polyester groups and use thereof as emulsifiers or dispersing agents
JP3242136B2 (ja) 油中水型乳化化粧料
JPH05105614A (ja) 油中水型乳化化粧料
JP4190176B2 (ja) 有機ケイ素重合体エマルジョンおよびその製造方法
JPH05262987A (ja) 含水性シリコーン組成物及びその製造方法並びに化粧料
MXPA01002567A (en) Organopolysiloxane gels for use in cosmetics
BR0100375B1 (pt) Géis de organopolissiloxano, processo para preparação de ditos géis, emulsões e produtos cosméticos contendo ditos géis
MXPA00004965A (en) Organopolysiloxane gels for use in cosmetics
JP2008088441A (ja) 有機ケイ素重合体エマルジョンおよびその製造方法

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Kind code of ref document: A1

Designated state(s): BE DE FR GB NL

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

AKX Designation fees paid

Free format text: BE DE FR GB NL

17Q First examination report despatched

Effective date: 20040608

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE DE FR GB NL

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60114488

Country of ref document: DE

Date of ref document: 20051208

Kind code of ref document: P

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: WACKER CHEMIE AG

NLT2 Nl: modifications (of names), taken from the european patent patent bulletin

Owner name: WACKER CHEMIE AG

Effective date: 20060125

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20060803

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20140121

Year of fee payment: 14

Ref country code: BE

Payment date: 20140121

Year of fee payment: 14

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150131

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20150801

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150801

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20200121

Year of fee payment: 20

Ref country code: GB

Payment date: 20200123

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20200121

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60114488

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20210124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20210124